According to different forms of gene mutation, different treatment schemes are selected. Now there are bio-targeted drug therapies. Since 2004, lung cancer, especially non-small cell lung cancer and non-squamous non-small cell lung cancer, should be treated according to whether there are driving genes, including EGFR, ALK and ROS, and more genes such as RAT and KRAS. In fact, it is necessary to do genetic testing to choose different treatment schemes and check these mutations according to different forms of genetic mutations. Mutation is the driving force of patients with positive gene mutation. Lung adenocarcinoma or large cell lung cancer is more common. In squamous cell carcinoma, especially small cell lung cancer, the positive power of trigger gene is relatively low. Therefore, if the patient is pathologically diagnosed as adenocarcinoma, at this time, the patient must do genetic testing, and tissue sections can be taken for genetic testing. Now there is also a liquid biopsy, and he can also do genetic testing through blood drawing and second-generation sequencing. According to the results of genetic testing, the next treatment method can be decided.
For more details about genetic testing, please consult Hyplos. Hyplos's medical laboratory has a top international gene sequencing platform and a perfect international standard quality system. It has passed CAP (American Pathologist Association) /EMQN (European Molecular Gene Diagnostic Quality Alliance)/Clinical Laboratory of China Ministry of Health and other authoritative certifications, and its business covers the whole process of tumor management, genetic disease screening, major infectious diseases (including COVID-19 nucleic acid) and other fields. ● Is it necessary to do genetic testing if you are not sick? A n experienced person has something to say. ......